In this exclusive Pharma IQ Interview Michael Elliott, CEO, Atrium Research and Eva-Lotta Westberg, Program Manager, AstraZeneca, discuss what vendors could be doing better to support interoperability, features vs. integration and the biggest challenges for an integration project. Westberg also shares key lessons learnt from embarking on an integration project and her future insights for the connected lab.
The Future of the Connected Lab: Features vs. Integration Full Interview with Eva-Lotta Westberg and Michael Elliott
Pharmaceuticals & Biotechnology Editor | 06/27/2013
